Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.
H&B there with
https://www.nahdionline.com/en/holland-and-barrett-slim-expert-with-slimbiome-21-sachets?q=slimbiome
along with as we were advised
https://www.nahdionline.com/en/healthy-food/meal-replacement?manufacturer=Gofigure
mol
New research started a few months ago
We are very pleased to welcome Blanka Isztl into our Nutrition and Health Team this summer on a very exciting study entitled “Preliminary pilot investigations into the effects of a mix of 2000mg of myoinositol, 200mg of folic acid and 50mg of D-chiro-inositol) and SlimBiome® supplement on body composition parameters, blood glucose response, lipid profile and hormones in women with PCOS”. Thank you to OptiBiotix Health Plc to provide in kind supplements for this research and Karol Sekulic for her nutrition PCOS diet consultation.
Drs Yvonne Jeanes and Adele Costabile are leading knowledge and skills exchange between experts in a medical setting (Consultant Gynaecologist Dr Giada Frontino) and our brilliant BSc Nutrition and Health graduate student, Blanka Isztl, from the School of Health and Life Sciences University of Roehampton. This collaboration has developed through BIG South London networking a truly great collaborative experience that merges clinical insights with ideas into scientific research. Great support of BIG South London consortium for funding . Blanka is now developing skills though real-world communication and laboratory skills development and application to enhance their immediate employability.
mol
Clio - we know it is
https://find-and-update.company-information.service.gov.uk/company/12276227/filing-history
mol
This hasn't been referenced as yet as far as i know - i may be wrong - in which case apologies
https://sk1n.co.uk/products
but the trading style of target identified by elrico coming up to a year ago
mol
I note that the company's website has been updated again since August 23 re 3% holding - not like an aim company to do so witin a month
Significant Shareholders
As at 31st August 2023
OptiBiotix Health Plc 27,190,639 15.70%
Seneca Partners Limited 16,475,376 9.52%
Tyndall Investment Management 13,165,553 7.60%
The University of Manchester 8,000,000 4.62%
As at 30th September 2023 significant shareholders that hold more than 3% of the share capital of SkinBioTherapeutics plc are detailed below:
OptiBiotix Health Plc 27,190,639 15.70%
Seneca Partners Limited 14,563,399 8.41%
Tyndall Investment Management 13,196,073 7.62%
The University of Manchester 8,000,000 4.62%
mol
27 october 2023
the chief executive of newcastle-headquartered life sciences business skinbiotherapeutics has spoken to insider about its acquisition drive and the "colossal" opportunities in its sector.
the listed company is a spin-out of the university of manchester, and is focused on skin health.
its proprietary platform technology, skinbiotix, is based upon discoveries made by dr. catherine o'neill and professor andrew mcbain about the positive impact of lysates, derived from probiotic bacteria, when applied to skin.
skinbiotherapeutics also develops "probiotic ****tail formulations", including a supplement called axisbiotix which helps address the symptoms associated with psoriasis.
chief executive stuart ashman explained that the company, which is generally b2b, generates "complex science", which is then licences, develops and pushes on to large multinationals such as sederma - the cosmetics division of croda international.
originally based out of macclesfield, the business is now headquartered in the core within newcastle's helix complex.
"we needed to put roots down somewhere, and there is a thriving scientific community within the biosphere, the core and the helix.
"it gave us the infrastructure and support that we truly crave and need.
"we are fully bought into the region and are very very proud to be there", added ashman.
in order to spreadhead growth, the company has now launched an acquisition drive and hopes to complete at least one accretive deal in the near term.
"we continue to work with multinationals and do b2b business but we feel that the products we've got, that are very consumer driven, now require faster pathways to the market.
"as a result, we are looking to buy a few businesses that already have those established retail and consumer driven channels", explained ashman.
he said: "in six to 12 months time, this company will look nothing like it does right now. that includes staffing up and increasing facilities - whether that's by hiring it or acquiring it. "
having worked to commercialise complex science for nearly 28 years, ashman concluded that he is "very optimistic" for the future of skinbiotherapeutics, adding: "i think the opportunities are colossal."
mol
PBX shortlisted
https://www.bioprocessonline.com/doc/cphi-barcelona-announces-pharma-award-finalists-0001
unfortunately we didn't win
https://europe.cphi.com/europe/en/awards/awards/past-ceremonies.html?_gl=1*1qn25im*_ga*MTA5MTEwOTI4Ni4xNjk4NTA5NTQz*_ga_ZJB8WQKN4E*MTY5ODUwOTU0Mi4xLjAuMTY5ODUwOTU0Mi42MC4wLjA.
mol
Aquae suggested on sbtx that I post this here as well as it may be of interest re our microbiome modulators and i tend to agree
https://www.labiotech.eu/opinion/microbiome-therapeutics-third-generation/
mol
Mind as we know
The Directors believe SkinBioTherapeutics is one of the first companies developing innovative technology
that is designed to promote skin health by harnessing the beneficial properties of probiotic bacteria and the
active components derived from them. The approach taken is to utilise a ‘lysate’ of probiotic bacteria as a
topical agent. The lysate is prepared by ultrasonic disruption of the bacterial cells. The lysate is then filtered
to remove any remaining living bacteria. The use of a lysate rather than live bacteria circumvents the possible
safety considerations associated with applying live bacteria to the skin, and also the potential formulation
difficulties of keeping bacteria alive in a cream.
SkinBioTherapeutics has generated an evidence base indicating that skin models can benefit from the
introduction of certain modulators in the form of lysates of probiotic bacteria. This has been achieved in skin
models through the SkinBiotix technology and its three “modes of action”, being protection, management
and restoration
mol
Https://www.labiotech.eu/opinion/microbiome-therapeutics-third-generation/
mol
Wellbiome also
https://www.walmart.com/ip/Optibiotix-Health-WellBiome-Mineral-Enriched-Prebiotic-Fibre-Complex/5103201330?athbdg=L1700&from=/search
mol
A search for slimbiome resulted in the undernoted
https://www.walmart.com/search?q=slimbiome
looks like reductions in price for branded products but as we know appetite control gummies and hikari slim contain slimbiome
just a bit of doodling this afternoon
mol
More info here
https://www.tatanq.com/who-we-are/
https://www.tatanq.com/fossence/
mol
Prebiotic potential of new sweeteners based on the simultaneous biosynthesis of galactooligosaccharides and enzymatically modified steviol glycosides
https://www.sciencedirect.com/science/article/abs/pii/S0308814623023798?via%3Dihub
mol
Bit of info
https://optibiotix.com/probiotix-health-highlights-lpldl-and-new-products-to-support-cardiometabolic-health-at-supplyside-west/
mol
And
https://www.myprotein.com/sports-nutrition/active-collagen-powder/13815063.html
Which I wasn’t aware of previously
mol
Also in the breakfast smoothie which is in stock
https://www.myprotein.com/sports-nutrition/breakfast-smoothie/13251950.html
mol